MACROGENICS, INC.
9704 Medical Center Drive
Rockville, MD 20850
December 31, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
|
Re:
|
MacroGenics, Inc.
Registration Statement on Form S-3
Filed December 23, 2019
File No. 333-235691
|
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MacroGenics, Inc. (the “Company”) hereby respectfully requests that
the effective date for the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern time, on January 3, 2020, or as soon as practicable thereafter.
Should you have any questions regarding the foregoing, please call the Company’s counsel, Eric W. Blanchard of Covington & Burling
LLP, who can be reached at (212) 841-1111.
Thank you for your assistance in this matter.
|
Very truly yours,
MACROGENICS, INC.
|
||
|
By:
|
/s/ Scott Koenig
|
|
|
Name:
|
Scott Koenig
|
|
|
Title:
|
President and Chief Executive Officer and Director
|
|